Clinical Trial Update: Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety, immunogenicity, and protective efficacy of two regimens of radiation-attenuated PfSPZ vaccine in healthy adults during natural t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2021-08-20